Paris, France, March 14, 2016—French President Mr. Hollande visited today BIOMILLENIA at its new laboratories and office during the inauguration of the Pierre-Gilles de Gennes Institute in Paris. Scientific founder Andrew Griffiths (right on picture) explained to Mr. Hollande the BIOMILLENIA ultrahigh-throughput microfluidics platform for developing tailor-made enzymes and production strains. This novel disruptive technology platform allows the culturing and growth of single microorganism cells or eucaryotic cells in extremely small volumes at unprecedented throughput, enabling the screening of up to 100 million variants in only 3 days, revolutionizing among others non-GMO production strain development.
Photo Copyright Présidence de la République